112 related articles for article (PubMed ID: 26371231)
1. The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats.
Smith IC; Vigna C; Levy AS; Denniss SG; Rush JW; Tupling AR
Physiol Rep; 2015 Sep; 3(9):. PubMed ID: 26371231
[TBL] [Abstract][Full Text] [Related]
2. Effects of buthionine sulfoximine treatment on diaphragm contractility and SR Ca2+ pump function in rats.
Tupling AR; Vigna C; Ford RJ; Tsuchiya SC; Graham DA; Denniss SG; Rush JW
J Appl Physiol (1985); 2007 Dec; 103(6):1921-8. PubMed ID: 17717121
[TBL] [Abstract][Full Text] [Related]
3. Buthionine sulfoximine treatment impairs rat diaphragm function.
Morales CF; Anzueto A; Andrade F; Brassard J; Levine SM; Maxwell LC; Lawrence RA; Jenkinson SG
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):915-9. PubMed ID: 7908245
[TBL] [Abstract][Full Text] [Related]
4. Modulation of rat erythrocyte antioxidant defense system by buthionine sulfoximine and its reversal by glutathione monoester therapy.
Rajasekaran NS; Devaraj NS; Devaraj H
Biochim Biophys Acta; 2004 Mar; 1688(2):121-9. PubMed ID: 14990342
[TBL] [Abstract][Full Text] [Related]
5. Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress.
Leichtweis S; Ji LL
Acta Physiol Scand; 2001 May; 172(1):1-10. PubMed ID: 11437734
[TBL] [Abstract][Full Text] [Related]
6. [Effect of D,L-buthionine-S,R-sulfoximine on the ratio of glutathione forms and the growth of tatar buckwheat calli].
Nigmatullina LR; Rumiantseva NI; Kostiukova IuA
Ontogenez; 2014; 45(1):50-62. PubMed ID: 25720265
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
[TBL] [Abstract][Full Text] [Related]
8. Chronic depletion of glutathione (GSH) and minimal modification of LDL in vivo: its prevention by glutathione mono ester (GME) therapy.
Rajasekaran NS; Sathyanarayanan S; Devaraj NS; Devaraj H
Biochim Biophys Acta; 2005 Jun; 1741(1-2):103-12. PubMed ID: 15955453
[TBL] [Abstract][Full Text] [Related]
9. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
10. Buthionine sulfoximine embryotoxicity is associated with prolonged AP-1 activation.
Ozolins TR; Harrouk W; Doerksen T; Trasler JM; Hales BF
Teratology; 2002 Oct; 66(4):192-200. PubMed ID: 12353216
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-specific gene expression is differentially influenced by intracellular glutathione level in FRTL-5 cells.
Lonigro R; Donnini D; Fabbro D; Perrella G; Damante G; Ambesi Impiombato FS; Curcio F
Endocrinology; 2000 Mar; 141(3):901-9. PubMed ID: 10698164
[TBL] [Abstract][Full Text] [Related]
12. Glutathione depression alters cellular mechanisms of skeletal muscle fatigue in early stage of recovery and prolongs force depression in late stage of recovery.
Watanabe D; Wada M
Am J Physiol Regul Integr Comp Physiol; 2023 Aug; 325(2):R120-R132. PubMed ID: 37212553
[TBL] [Abstract][Full Text] [Related]
13. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells.
Hong H; Lu Y; Ji ZN; Liu GQ
J Neurochem; 2006 Sep; 98(5):1465-73. PubMed ID: 16923159
[TBL] [Abstract][Full Text] [Related]
15. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
Chen G; Zeller WJ
Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
[TBL] [Abstract][Full Text] [Related]
17. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
18. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
Coursin DB; Cihla HP
Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501
[TBL] [Abstract][Full Text] [Related]
19. The effect of buthionine sulfoximine on the glutathione level in goldfish tissues.
Lushchak VI; Hermes-Lima M
Ukr Biokhim Zh (1999); 2005; 77(3):35-8. PubMed ID: 16566126
[TBL] [Abstract][Full Text] [Related]
20. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC; Denekamp J; Minchinton AI
Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
